Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
13.81
-0.68 (-4.69%)
At close: Feb 27, 2026, 4:00 PM EST
13.55
-0.26 (-1.88%)
After-hours: Feb 27, 2026, 7:56 PM EST
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $4.34 billion as of February 27, 2026. Its market cap has increased by 79.17% in one year.
Market Cap
4.34B
Enterprise Value
6.82B
1-Year Change
79.17%
Ranking
Category
Stock Price
$13.81
Market Cap Chart
Since May 7, 2018, Amneal Pharmaceuticals's market cap has increased from $1.91B to $4.34B, an increase of 127.70%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 4.34B | 9.60% |
| Dec 31, 2025 | 3.96B | 61.41% |
| Dec 31, 2024 | 2.45B | 31.88% |
| Dec 29, 2023 | 1.86B | 517.28% |
| Dec 30, 2022 | 301.44M | -57.87% |
| Dec 31, 2021 | 715.49M | 6.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 5.01B |
| Lantheus Holdings | 4.97B |
| Kiniksa Pharmaceuticals International, | 3.41B |
| Hims & Hers Health | 3.31B |
| Prestige Consumer Healthcare | 3.28B |
| Supernus Pharmaceuticals | 3.14B |
| HUTCHMED (China) | 2.49B |
| Phibro Animal Health | 2.21B |